906 results Stibbe advises Delta Lloyd and ABN AMRO Insurances Advising Delta Lloyd and ABN AMRO Insurances in outsourcing of its insurance activities by ABN AMRO Bank. Stibbe advises leading US car rental company Stibbe advised a leading US car rental company on Luxembourg company law aspects related to its acquisition of PSA Peugeot Citroën’s car rental subsidiary, Citer SA and its Spanish subsidiary Atesa through a Luxembourg structure. Stibbe advises Friesland Bank Advising Friesland Bank on its separation from Stichting Friesland Bank and its merger into Rabobank Nederland. Nina Coussement Associate Brussels Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises the Gemeentelijke Holding Stibbe advised the directors of the Gemeentelijke Holding, one of the main historical shareholders of Dexia NV, throughout the entire crisis period. Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments. Stibbe advises The Blackstone Group Advising the Blackstone Group on Dutch corporate, real estate, finance, tax and employment law aspects of its acquisition of the Mint Hotels group, also known as City Inn. Stibbe advises Luxembour holding company Stibbe advised a Luxembourg holding company on the EUR 1.05 billion acquisition of KBC’s private subsidiary KB Lux. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises APG Advising APG on the sale of its holding of ProLogis European Properties (PEPR). Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Stibbe advises Canon Advising Canon on its EUR 730 million all cash public offer for all shares of Océ. Together, Canon and Océ aim to create the overall number one presence in the printing industry. Canon also agreed to pay EUR 65 million to buy Oce’s preferred shares. Stibbe advises Super de Boer Advising Super de Boer in relation to the EUR 550 million offer made by Jumbo Groep regarding the acquisition of the entire business of Super de Boer by means of an acquisition of all its assets and liabilities. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises Vandemoortele Stibbe assisted Vandemoortele with the EUR 325 million divestment of its soy foods division, known under the trademarks Alpro and Provamel, to Dean Foods Company. Pagination Previous page Page 43 Current page 44 Page 45 Page 46 Next page
Stibbe advises Delta Lloyd and ABN AMRO Insurances Advising Delta Lloyd and ABN AMRO Insurances in outsourcing of its insurance activities by ABN AMRO Bank.
Stibbe advises leading US car rental company Stibbe advised a leading US car rental company on Luxembourg company law aspects related to its acquisition of PSA Peugeot Citroën’s car rental subsidiary, Citer SA and its Spanish subsidiary Atesa through a Luxembourg structure.
Stibbe advises Friesland Bank Advising Friesland Bank on its separation from Stichting Friesland Bank and its merger into Rabobank Nederland.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises the Gemeentelijke Holding Stibbe advised the directors of the Gemeentelijke Holding, one of the main historical shareholders of Dexia NV, throughout the entire crisis period.
Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments.
Stibbe advises The Blackstone Group Advising the Blackstone Group on Dutch corporate, real estate, finance, tax and employment law aspects of its acquisition of the Mint Hotels group, also known as City Inn.
Stibbe advises Luxembour holding company Stibbe advised a Luxembourg holding company on the EUR 1.05 billion acquisition of KBC’s private subsidiary KB Lux.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Stibbe advises Canon Advising Canon on its EUR 730 million all cash public offer for all shares of Océ. Together, Canon and Océ aim to create the overall number one presence in the printing industry. Canon also agreed to pay EUR 65 million to buy Oce’s preferred shares.
Stibbe advises Super de Boer Advising Super de Boer in relation to the EUR 550 million offer made by Jumbo Groep regarding the acquisition of the entire business of Super de Boer by means of an acquisition of all its assets and liabilities.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises Vandemoortele Stibbe assisted Vandemoortele with the EUR 325 million divestment of its soy foods division, known under the trademarks Alpro and Provamel, to Dean Foods Company.